The Definitive Guide to Ragaglitazar
within a mouse product, providing genetic validation of CRK12:CYC9 for a novel drug goal for trypanosomiasis. Further, practical characterisation of CRK12 and CYC9 working with RNA interference reveals roles for these proteins in endocytosis and cytokinesis, respectively.and in vivo antileishmanial efficacy of a mix therapy of diminazene and artesu